Borrelia burgdorferi specific serum and cerebrospinal fluid antibodies in Lyme neuroborreliosis.

[1]  F. Strle,et al.  Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis , 2022, Emerging infectious diseases.

[2]  R. Dattwyler,et al.  Detection of IFN-ɣ Secretion in Blood Samples Collected Before and After Treatment of Varying Stages of Lyme Disease. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Steere,et al.  Laboratory Diagnosis of Lyme Borreliosis , 2021, Clinical Microbiology Reviews.

[4]  T. Blauwkamp,et al.  Detection of Borrelia burgdorferi Cell-free DNA in Human Plasma Samples for Improved Diagnosis of Early Lyme Borreliosis. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  B. Kullberg,et al.  Lyme borreliosis: diagnosis and management , 2020, BMJ.

[6]  L. Airas,et al.  Oral doxycycline compared to intravenous ceftriaxone in the treatment of Lyme neuroborreliosis: a multicentre, equivalence, randomized, open-label trial. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Hänninen,et al.  Tick-borne pathogens in Finland: comparison of Ixodes ricinus and I. persulcatus in sympatric and parapatric areas , 2018, Parasites & Vectors.

[8]  J. Ollgren,et al.  Population-based Borrelia burgdorferi sensu lato seroprevalence and associated risk factors in Finland. , 2017, Ticks and tick-borne diseases.

[9]  F. Strle,et al.  Course and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory Findings. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Steere,et al.  Lyme borreliosis , 2016, Nature Reviews Disease Primers.

[11]  G. Wormser,et al.  Development of a metabolic biosignature for detection of early Lyme disease. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  H. Gerritsen,et al.  High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  V. Fingerle,et al.  EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis , 2010, European journal of neurology.

[14]  F. Strle,et al.  Lyme borreliosis: a European perspective on diagnosis and clinical management , 2009, Current opinion in infectious diseases.

[15]  F. Strle,et al.  Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  T. Klabunde,et al.  Crystal Structure of Lyme Disease Variable Surface Antigen VlsE of Borrelia burgdorferi * , 2002, The Journal of Biological Chemistry.

[17]  R Ruthazer,et al.  Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.